Cann Group Ltd is one of 64 new shares added to the All Ordinaries this quarter

This morning S&P Dow Jones Indices announced its March 2018 quarterly rebalance of the S&P/ASX Indices.

Whilst there are changes across all of its major indices, the All Ordinaries (Index: ^AXAO) (ASX: XAO) is by far the index with the most going on this quarter.

A total of 64 new shares will be added to the index at the expense of the same number of existing constituents on March 19.

Here is a quick summary of some of the changes being made this quarter:


There have been a number of eyebrow-raising additions to the index this quarter.

This includes the addition of the first medicinal cannabis company on a major Australian index – Cann Group Ltd (ASX: CAN).

New additions from the resources sector include mineral exploration companies Avz Minerals Ltd (ASX: AVZ), Argosy Minerals Limited (ASX: AGY), and Artemis Resources Ltd (ASX: ARV).

Infant formula hopeful Bubs Australia Ltd (ASX: BUB) will also be a new entrant to the index.

Finally, a few tech shares that have been added to the All Ordinaries include LiveHire Ltd (ASX: LVH), Yojee Ltd (ASX: YOJ), Fastbrick Robotics Ltd (ASX: FBR) and GetSwift Ltd (ASX: GSW).


A lot of the companies making way for these new additions will not be a surprise to investors.

These include the embattled CBL Corporation Limited (ASX: CBL), Innate Immunotherapeutics Ltd (ASX: IIL), Mcgrath Ltd (ASX: MEA), Resapp Health Ltd (ASX: RAP), and Yowie Group Ltd (ASX: YOW).

I think it is fair to say that all five companies have had a disastrous 12 months, so their removal would have been largely expected.

Elsewhere, other removals of note include Billabong International Limited (ASX: BBG), GBST Holdings Limited (ASX: GBT), and Sundance Energy Australia Ltd (ASX: SEA).

What now?

When the All Ordinaries rebalances it often provides a short-term lift to the shares added to the index and the reverse to shares removed from the index.

This is largely because index funds that track the market need to buy or sell shares accordingly. But also because some fund managers are restricted from buying shares that are not included in the All Ordinaries. This could mean they have to dump shares that have been kicked out or can now buy shares that they have been previously unable to buy.

I wouldn't necessarily act on this news, instead I would just focus on buying quality shares like these that are destined for big things in my opinion.

Top 3 ASX Blue Chips To Buy In 2018

For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked..

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool’s in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool’s Top 3 Blue Chip Stocks for 2018."

Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.

The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies moves – we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of CBL Limited. The Motley Fool Australia has recommended GBST Holdings Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.